The Pharmacogenomics Journal

TABLE 3

FROM:

Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication

J Kirchheiner, H Schmidt, M Tzvetkov, J-Tha Keulen, J Lötsch, I Roots and J Brockmöller

BACK TO ARTICLE

Table 3. Metabolic ratios in urine of codeine and C6G and the demethylated metabolites from the 0–6 h and the 6–12 h interval of urine collection

  Fine activity Codeine/morphine 0–6 h (codeine + C6G)/ (morphine+M3G+M6G) 0–6 h Codeine/morphine 6–12 h (codeine+C6G)/ (morphine+M3G+M6G) 6–12 h
PM0 (n=3)198 (143–599)363 (257–652)68 (46–278)255 (162–442)
EM1.5 (n=3)28 (16–31)15 (12–17)18 (15–20)13 (12–15)
 2 (n=6)19 (9.9–28)10 (5.9–16)9.4 (5.6–19)8.4 (5.6–12)
UM2.5 (n=4)17 (13–19)10 (6.2–11)14 (5.6–16)8.6 (5.1–9.1)
 3 (n=7)18 (6.3–43)8.9 (6.2–16)12 (4.5–30)7.4 (5.5–12.8)
 P* NS0.01NS0.029

 Abbreviations: EM, extensive metabolizers; PM, poor metabolizers; UM, ultra-fast metabolizers.

 Data are given as median and range. Significance was tested with the non-parametric Jonckheere–Terpstra Trend test with exclusion of the PM group. Test was performed only for differences between EM and UM.

BACK TO ARTICLE